Products > IHC > Antibodies for immunohistochemistry

Antibodies for immunohistochemistry

Reach out to the antigen


In addition to the well-known own brand Zytomed Systems, the current program includes tried and tested reagents from Diagnostic Biosystems, BioCare Medical, Zeta Corporation among others. We are constantly testing new antibodies and detection systems to meet the specific requirements of the laboratories and scientific users in the best possible way. Most of the primary antibodies are available both as concentrates and as ready-to-use products.


Sorry, no results could be found for your request.
Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.
Product Clone Order no.
Host Rabbit
Clone SP271
Format Concentrate
Method P, WB, FL
Pretreatment EDTA
Positive control Cervical Carcinoma
Dilution 1:100
Isotype Rabbit IgG
Immunogen Synthetic peptide corresponding to the C-terminus of human p14ARF protein
Localization Nucleus
p14ARF
SP271 501-5714
Host Mouse+Rabbit
Clone BC42+EPR20330
Format Ready-to-use
Method P
Positive control Melanoma
Dilution -
Isotype Mouse IgG1 kappa + Rabbit IgG
Localization Nuclear and cytoplasmic (Brown) + Nucleus and cell membrane (Red)
p16 + PRAME
BC42+EPR20330 ALI3256DSG7
Host Mouse+Rabbit
Clone BC42+EPR20330
Format Ready-to-use
Method P
Pretreatment EDTA
Positive control Melanoma
Dilution -
Isotype Mouse IgG1 kappa + Rabbit IgG
Localization Nuclear and cytoplasmic (Brown) + Nucleus and cell membrane (Red)
p16 + PRAME
BC42+EPR20330 API3256DSAA
Host Mouse
Clone BC42
Format Concentrate
Method P
Pretreatment Citrate
Positive control Tonsil, Cervical Cancer
Dilution 1:100
Isotype IgG1 kappa
Localization Nuclear and cytoplasmic
p16 INK4a
BC42 ACI3231A
Host Mouse
Clone BC42
Format Concentrate
Method P
Pretreatment Citrate
Positive control Tonsil, Cervical Cancer
Dilution 1:100
Isotype IgG1 kappa
Localization Nuclear and cytoplasmic
p16 INK4a
BC42 ACI3231C
Host Mouse
Clone BC42
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Tonsil, Cervical Cancer
Dilution -
Isotype IgG1 kappa
Localization Nuclear and cytoplasmic
p16 INK4a
BC42 API3231AA
Host Mouse
Clone BC42
Format Ready-to-use
Method P
Pretreatment CC1
Positive control Tonsil, Cervical Cancer
Dilution -
Isotype IgG1 kappa
Localization Nucleus and cytoplasmic
p16 INK4a
BC42 AVI3231G
Host Mouse
Clone BC42
Format Ready-to-use
Method P
Pretreatment CC1
Positive control Tonsil, Cervical Cancer
Dilution -
Isotype IgG1 kappa
Localization Nucleus and cytoplasmic
p16 INK4a
BC42 AVI3231G25
Host Mouse and Rabbit
Clone JC2 + SP6
Format RTU
Method P
Positive control Cervical CA
Isotype IgG2a / Rabbit IgG
Immunogen Synthetic peptide from 62 base pair region of the human Ki-67 antigen. And purified recombinant prokaryotic full length human P16 INK4 protein
Localization Cytoplasmic and Nuclear
p16/Ki-67 Cocktail
JC2 + SP6 PDRMM001R
Host Mouse
Clone G175-405
Format Concentrate
Reactivity -
Method P
Positive control Cervical squamous cell carcinoma.
Dilution 1:100
Isotype IgG2 /κ
Immunogen A synthetic peptide from the C-terminus of human p16INK4a
Localization Cytoplasm and Nucleus
p16INK4a
G175-405 Z2117ML
Host Mouse
Clone G175-405
Format Ready-to-use
Reactivity -
Method P
Positive control Cervical squamous cell carcinoma.
Dilution -
Isotype IgG2 /κ
Immunogen A synthetic peptide from the C-terminus of human p16INK4a
Localization Cytoplasm and Nucleus
p16INK4a
G175-405 Z2117MP
Host Mouse
Clone G175-405
Format Concentrate
Reactivity -
Method P
Positive control Cervical squamous cell carcinoma.
Dilution 1:100
Isotype IgG2 /κ
Immunogen A synthetic peptide from the C-terminus of human p16INK4a
Localization Cytoplasm and Nucleus
p16INK4a
G175-405 Z2117MS
Host Mouse
Clone G175-405
Format Concentrate
Reactivity -
Method P
Positive control Cervical squamous cell carcinoma.
Dilution 1:100
Isotype IgG2 /κ
Immunogen A synthetic peptide from the C-terminus of human p16INK4a
Localization Cytoplasm and Nucleus
p16INK4a
G175-405 Z2117MT
Host Mouse
Clone JC2
Format Concentrate
Reactivity -
Method P
Positive control Cervical squamous cell carcinoma.
Dilution 1:100 - 1:200
Isotype IgG2a /κ
Immunogen Purified recombinant prokaryotic full length human p16INK4a protein
Localization Cytoplasm and Nucleus
p16INK4a
JC2 Z2567ML
Host Mouse
Clone JC2
Format Ready-to-use
Reactivity -
Method P
Positive control Cervical squamous cell carcinoma
Dilution -
Isotype IgG2a /κ
Immunogen Purified recombinant prokaryotic full length human p16INK4a protein
Localization Cytoplasm and Nucleus
p16INK4a
JC2 Z2567MP
Host Mouse
Clone JC2
Format Concentrate
Reactivity -
Method P
Positive control Cervical squamous cell carcinoma.
Dilution 1:100 - 1:200
Isotype IgG2a /κ
Immunogen Purified recombinant prokaryotic full length human p16INK4a protein
Localization Cytoplasm and Nucleus
p16INK4a
JC2 Z2567MS
Host Mouse
Clone JC2
Format Concentrate
Reactivity -
Method P
Positive control Cervical squamous cell carcinoma.
Dilution 1:100 - 1:200
Isotype IgG2a /κ
Immunogen Purified recombinant prokaryotic full length human p16INK4a protein
Localization Cytoplasm and Nucleus
p16INK4a
JC2 Z2567MT
Host Rabbit
Clone ZR288
Format Concentrate
Reactivity -
Method P
Positive control Colon carcinoma
Dilution 1:100 - 1:200
Isotype IgG
Immunogen Purified human recombinant fusion p21 protein
Localization Nuclear
p21
ZR288 Z2602RL
Host Rabbit
Clone ZR288
Format ready-to-use
Reactivity -
Method P
Positive control Colon carcinoma
Dilution ---
Isotype IgG
Immunogen Purified human recombinant fusion p21 protein
Localization Nuclear
p21
ZR288 Z2602RP
Host Rabbit
Clone ZR288
Format Concentrate
Reactivity -
Method P
Positive control Colon carcinoma
Dilution 1:100 - 1:200
Isotype IgG
Immunogen Purified human recombinant fusion p21 protein
Localization Nuclear
p21
ZR288 Z2602RS
Host Rabbit
Clone ZR288
Format Concentrate
Reactivity -
Method P
Positive control Colon carcinoma
Dilution 1:100 - 1:200
Isotype IgG
Immunogen Purified human recombinant fusion p21 protein
Localization Nuclear
p21
ZR288 Z2602RT
Host Mouse
Clone DCS-72.F6
Format Concentrate
Method F, P, IP
Pretreatment Citrate
Positive control Colon Carcinoma
Dilution 1:25 - 1:50
Isotype Mouse IgG1
Localization Nucleus
p27 (KIP1)
DCS-72.F6 MOB281
Host Mouse
Clone DCS-72.F6
Format Concentrate
Method F, P, IP
Pretreatment Citrate
Positive control Colon Carcinoma
Dilution 1:25 - 1:50
Isotype Mouse IgG1
Localization Nucleus
p27 (KIP1)
DCS-72.F6 MOB281-01
Host Mouse
Clone DCS-72.F6
Format Concentrate
Method F, P, IP
Pretreatment Citrate
Positive control Colon Carcinoma
Dilution 1:25 - 1:50
Isotype Mouse IgG1
Localization Nucleus
p27 (KIP1)
DCS-72.F6 MOB281-05
Host Mouse
Clone DCS-72.F6
Format ready-to-use
Method F, P, IP
Pretreatment Citrate
Positive control Colon Carcinoma
Dilution ---
Isotype Mouse IgG1
Localization Nucleus
p27 (KIP1)
DCS-72.F6 PDM245
Host Mouse
Clone SX53G8
Format Concentrate
Reactivity -
Method P
Positive control Colon carcinoma.
Dilution 1:50 - 1:200
Isotype IgG1 /κ
Immunogen Purified glutathione S-transferase (GST)-p27Kip1 fusion protein
Localization Nucleus
p27Kip1
SX53G8 Z2158ML
Host Mouse
Clone SX53G8
Format Ready-to-use
Reactivity -
Method P
Positive control Colon carcinoma.
Dilution -
Isotype IgG1 /κ
Immunogen Purified glutathione S-transferase (GST)-p27Kip1 fusion protein
Localization Nucleus
p27Kip1
SX53G8 Z2158MP
Host Mouse
Clone SX53G8
Format Concentrate
Reactivity -
Method P
Positive control Colon carcinoma.
Dilution 1:50 - 1:200
Isotype IgG1 /κ
Immunogen Purified glutathione S-transferase (GST)-p27Kip1 fusion protein
Localization Nucleus
p27Kip1
SX53G8 Z2158MS
Host Mouse
Clone SX53G8
Format Concentrate
Reactivity -
Method P
Positive control Colon carcinoma.
Dilution 1:50 - 1:200
Isotype IgG1 /κ
Immunogen Purified glutathione S-transferase (GST)-p27Kip1 fusion protein
Localization Nucleus
p27Kip1
SX53G8 Z2158MT
Host Rabbit
Clone polyclonal
Format Ready-to-use
Method P
Pretreatment EDTA
Positive control Prostate
Isotype Ig
Immunogen A synthetic peptide corresponding to amino acids 5-17 of human p40
Localization Nucleus
p40
polyclonal PDR055
Host Rabbit
Clone polyclonal
Format Concentrate
Method P
Pretreatment EDTA
Positive control Prostate
Dilution 1:50 - 1:100
Isotype Ig
Immunogen A synthetic peptide corresponding to amino acids 5-17 of human p40
Localization Nucleus
p40
polyclonal RP163
Host Rabbit
Clone polyclonal
Format Concentrate
Method P
Pretreatment EDTA
Positive control Prostate
Dilution 1:50 - 1:100
Isotype Ig
Immunogen A synthetic peptide corresponding to amino acids 5-17 of human p40
Localization Nucleus
p40
polyclonal RP163-01
Host Rabbit
Clone polyclonal
Format Concentrate
Method P
Pretreatment EDTA
Positive control Prostate
Dilution 1:50 - 1:100
Isotype Ig
Immunogen A synthetic peptide corresponding to amino acids 5-17 of human p40
Localization Nucleus
p40
polyclonal RP163-05
Host Rabbit
Clone ZR8
Format Concentrate
Reactivity -
Method P
Positive control Lung squamous cell carcinoma.
Dilution 1:100 - 1:200
Isotype IgG
Immunogen Synthesized polypeptides from N-terminal domain of p63
Localization Nucleus
p40
ZR8 Z2004RL
Host Rabbit
Clone ZR8
Format Ready-to-use
Reactivity -
Method P
Positive control Lung squamous cell carcinoma.
Dilution -
Isotype IgG
Immunogen Synthesized polypeptides from N-terminal domain of p63
Localization Nucleus
p40
ZR8 Z2004RP
Host Rabbit
Clone ZR8
Format Concentrate
Reactivity -
Method P
Positive control Lung squamous cell carcinoma.
Dilution 1:100 - 1:200
Isotype IgG
Immunogen Synthesized polypeptides from N-terminal domain of p63
Localization Nucleus
p40
ZR8 Z2004RS
Host Rabbit
Clone ZR8
Format Concentrate
Reactivity -
Method P
Positive control Lung squamous cell carcinoma.
Dilution 1:100 - 1:200
Isotype IgG
Immunogen Synthesized polypeptides from N-terminal domain of p63
Localization Nucleus
p40
ZR8 Z2004RT
Host Mouse
Clone BC28
Format Concentrate
Method P
Pretreatment Citrate
Positive control Lung squamous cell carcinoma
Dilution 1:50 - 1:100
Isotype Rabbit IgG
Immunogen Synthetic peptide corresponding to amino acids 5-17 of human p40
Localization Nucleus
p40 (M)
BC28 ACI3066A
Host Mouse
Clone BC28
Format Concentrate
Method P
Pretreatment Citrate
Positive control Lung squamous cell carcinoma
Dilution 1:50 - 1:100
Isotype Rabbit IgG
Immunogen Synthetic peptide corresponding to amino acids 5-17 of human p40
Localization Nucleus
p40 (M)
BC28 ACI3066C
Host Mouse
Clone BC28
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Lung squamous cell carcinoma
Dilution -
Isotype Rabbit IgG
Immunogen Synthetic peptide corresponding to amino acids 5-17 of human p40
Localization Nucleus
p40 (M)
BC28 API3066AA
Host Mouse
Clone BC28
Format Ready-to-use
Method P
Pretreatment Citrate
Positive control Lung squamous cell carcinoma
Dilution -
Isotype Rabbit IgG
Immunogen Synthetic peptide corresponding to amino acids 5-17 of human p40
Localization Nucleus
p40 (M)
BC28 API3066H
Host Rabbit
Clone SP161
Format Concentrate
Method P
Pretreatment Citrate
Positive control Colon Carcinoma
Dilution 1:100
Isotype Rabbit IgG
Immunogen Recombinant human full length wild type p53 protein
Localization Nucleus
p53
SP161 516-4614
Host Rabbit
Clone EP9
Format Ready-to-use
Method P
Pretreatment CC1
Positive control Breast cancer, colon cancer
Dilution -
Isotype Rabbit IgG
Localization Nucleus
p53
EP9 AVI298G
Host Mouse
Clone BP53-12
Format Ready-to-use
Method P
Pretreatment EDTA
Positive control Breast carcinoma, colon carcinoma
Dilution -
Isotype IgG2a
Immunogen Recombinant protein corresponding to wild type human p53
Localization Nucleus
p53
BP53-12 BMS064
Host Rabbit
Clone EP9
Format Concentrate
Method P
Pretreatment Reveal modified Citrate pH 6.0
Positive control Breast cancer, colon cancer
Dilution 1:100 - 1:200
Isotype Rabbit IgG
Localization Nuclear
p53
EP9 CME298AK
Host Rabbit
Clone EP9
Format Concentrate
Method P
Pretreatment Reveal modified Citrate pH 6.0
Positive control Breast cancer, colon cancer
Dilution 1:100 - 1:200
Isotype Rabbit IgG
Localization Nuclear
p53
EP9 CME298BK
Host Mouse
Clone DO7
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Breast Carcinoma
Dilution 1:25 - 1:100
Isotype Mouse IgG2b
Localization Nucleus
p53
DO7 MOB082
Host Mouse
Clone DO7
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Breast Carcinoma
Dilution 1:25 - 1:100
Isotype Mouse IgG2b
Localization Nucleus
p53
DO7 MOB082-01
Host Mouse
Clone DO7
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Breast Carcinoma
Dilution 1:25 - 1:100
Isotype Mouse IgG2b
Localization Nucleus
p53
DO7 MOB082-05
Host Mouse
Clone BP53-12
Format Ready-to-use
Method F, P
Pretreatment Citrate
Dilution -
Isotype Mouse IgG2a
Localization Nucleus
p53
BP53-12 MSG020
< Page 49 of 65 >
Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.
Product Clone Order no.

Key to the method:

EL = ELISA; F = Frozen section IHC; FL = Flow Cytometry; IF = Immunfluoreszenz; IP = Immunoprecipitation; P = Paraffin section IHC; WB = Western Blot; u. a. = and others

Product availability

Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.

Got it